Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01183780
Show Display Options
Rank Status Study
1 Active, not recruiting A Study in Second Line Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: Ramucirumab;   Drug: Irinotecan;   Biological: Placebo;   Drug: Folinic Acid;   Drug: 5-Fluorouracil

Indicates status has not been verified in more than two years